Net Income

Canada has won the right to host the new Defence, Security and Resilience Bank. Now, a fierce battle erupts between its top cities for the 3,500 jobs.

Facing mounting debt and a harsh market, the Canadian diamond miner sells assets to a related party and extends loans, buying just two months of time.

The 2026 Lexus ES 350h arrives with a powerful new hybrid system, AWD, and a tech-rich interior, challenging the luxury sedan market with its multi-pathway strategy.

Over 100 American clergy defend the Family Federation in Japan, framing a local legal battle over finances as a global fight for religious freedom.

As explosive growth meets dry Texas landscape, a new high-tech arsenal gives firefighters a crucial edge in protecting the wildland-urban interface.

EltaMD's new campaign uses art and a 'buy one, give one' model to promote daily SPF use and support melanoma research. Here's a closer look.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

McEwen Inc. completes its acquisition of Golden Lake, integrating the Jewel Ridge project to create a long-life gold mining complex in Nevada's core.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

A massive lawsuit plunged the brewer into a deep quarterly loss, overshadowing operational gains and highlighting struggles in a shifting beverage market.

The chemical giant's Q1 earnings fell year-over-year, but strong sequential growth and a "net upside" from global conflict fuel an optimistic 2026 outlook.

The consulting firm posted double-digit Q1 growth, fueled by its critical role in securing AI-powered products and fortifying energy infrastructure.

With cash burn rising, Summit Therapeutics races toward a November FDA decision on its novel cancer drug ivonescimab and a major data reveal at ASCO.

Facing mounting losses, BayFirst Financial raises $80M and names a new CEO in a bold gambit to recapitalize and refocus on its Tampa Bay roots.

MPS smashes Q1 revenue records, fueled by a 98% surge in its AI data segment. The company now eyes a massive $6 billion capacity expansion.

With record growth and raised guidance, the REIT leverages market trends and strategic partnerships to solidify its leadership in medical real estate.

Amid a Q2 net loss driven by rising mortgage rates and geopolitical tension, Beazer Homes accelerates share repurchases, signaling confidence in its strategy.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

Following a record-breaking quarter, Enova's executives will detail their AI-powered growth engine and future outlook at the Needham investor conference.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.